Literature DB >> 33436803

Apparent diffusion coefficient as a prognostic factor in clival chordoma.

Hyeong-Cheol Oh1, Chang-Ki Hong1, Kyu-Sung Lee1, Yoon Jin Cha2, Sung Jun Ahn3, Sang Hyun Suh3, Hun Ho Park4.   

Abstract

Clival chordoma is a rare disease with high recurrence rates even after a combination of surgical resection and radiotherapy. Apparent diffusion coefficient (ADC) has been used to evaluate aggressive features of chordoma, but its utility for clival chordoma has not been explored specifically. In this study, the utility of preoperative ADC values was analyzed for predicting tumor progression and recurrence in patients with clival chordoma. Between 2012 and 2019, a total of 30 operated cases were analyzed with available preoperative ADC data. Receiver operating characteristic (ROC) analysis was used to obtain ADC cutoff values for predicting tumor aggressiveness. The mean and minimum ADC values were significantly lower in the aggressive tumor group than in the stable tumor group (both P < 0.001). ROC analysis showed that a mean cutoff ADC value of 1198 × 10-6 mm2/s and minimum ADC value of 895.5 × 10-6 mm2/s could be used to predict aggressive features of clival chordoma. Subtotal resection, partial resection, and mean and minimum ADC values that were lower than cutoff values were negative predictors of overall survival and progression-free survival. In conclusion, mean and minimum ADC values could be useful in predicting aggressiveness of clival chordoma.

Entities:  

Mesh:

Year:  2021        PMID: 33436803      PMCID: PMC7804259          DOI: 10.1038/s41598-020-79894-8

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  36 in total

Review 1.  Chordoma: current concepts, management, and future directions.

Authors:  Brian P Walcott; Brian V Nahed; Ahmed Mohyeldin; Jean-Valery Coumans; Kristopher T Kahle; Manuel J Ferreira
Journal:  Lancet Oncol       Date:  2012-02       Impact factor: 41.316

2.  Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies.

Authors:  Salvatore Di Maio; Nancy Temkin; Dinesh Ramanathan; Laligam N Sekhar
Journal:  J Neurosurg       Date:  2011-08-05       Impact factor: 5.115

3.  MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders.

Authors:  D Le Bihan; E Breton; D Lallemand; P Grenier; E Cabanis; M Laval-Jeantet
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

4.  Chordomas and cartilaginous tumors at the skull base.

Authors:  M J Heffelfinger; D C Dahlin; C S MacCarty; J W Beabout
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

Review 5.  Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients.

Authors:  Muneyoshi Yasuda; Damien Bresson; Salvatore Chibbaro; Jan F Cornelius; Marc Polivka; Loic Feuvret; Masakazu Takayasu; Bernard George
Journal:  Neurosurg Rev       Date:  2011-08-24       Impact factor: 3.042

Review 6.  Contemporary management of clival chordomas.

Authors:  Raewyn G Campbell; Daniel M Prevedello; Leo Ditzel Filho; Brad A Otto; Ricardo L Carrau
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2015-04       Impact factor: 2.064

Review 7.  Proton radiation therapy for chordomas and chondrosarcomas of the skull base.

Authors:  E B Hug; J D Slater
Journal:  Neurosurg Clin N Am       Date:  2000-10       Impact factor: 2.509

8.  Diffusion-weighted MR imaging: diagnosing atypical or malignant meningiomas and detecting tumor dedifferentiation.

Authors:  V A Nagar; J R Ye; W H Ng; Y H Chan; F Hui; C K Lee; C C T Lim
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

9.  Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.

Authors:  K W Yeom; R M Lober; B C Mobley; G Harsh; H Vogel; R Allagio; M Pearson; M S B Edwards; N J Fischbein
Journal:  AJNR Am J Neuroradiol       Date:  2012-11-01       Impact factor: 3.825

10.  Small-molecule targeting of brachyury transcription factor addiction in chordoma.

Authors:  Tanaz Sharifnia; Mathias J Wawer; Ting Chen; Qing-Yuan Huang; Barbara A Weir; Ann Sizemore; Matthew A Lawlor; Amy Goodale; Glenn S Cowley; Francisca Vazquez; Christopher J Ott; Joshua M Francis; Slim Sassi; Patricia Cogswell; Hadley E Sheppard; Tinghu Zhang; Nathanael S Gray; Paul A Clarke; Julian Blagg; Paul Workman; Josh Sommer; Francis Hornicek; David E Root; William C Hahn; James E Bradner; Kwok K Wong; Paul A Clemons; Charles Y Lin; Joanne D Kotz; Stuart L Schreiber
Journal:  Nat Med       Date:  2019-01-21       Impact factor: 53.440

View more
  1 in total

1.  The role of apparent diffusion coefficient as a predictive factor for tumor recurrence in patients with cerebellopontine angle epidermoid tumor.

Authors:  Hyeong-Cheol Oh; Chang-Ki Hong; Jihwan Yoo; Kyu-Sung Lee; Yoon Jin Cha; Sung Jun Ahn; Sang Hyun Suh; Hun Ho Park
Journal:  Neurosurg Rev       Date:  2021-09-28       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.